Dry Age-Related Macular Degeneration Market to Reach USD 10.57 Billion by 2032 with 9.1% CAGR – SNS Insider
October 17, 2024 08:56 ET
|
SNS Insider pvt ltd
Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports that the Dry Age-related Macular Degeneration Market, valued at USD 4.83 billion in 2023, is expected to reach USD 10.57 billion by the...
Age-related Macular Degeneration Drugs Market to Hit USD 17.37 Billion by 2029 with 10.7% CAGR | MarketsandMarkets™
October 11, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Delray Beach, FL, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The global AMD drugs market is set to grow from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, reflecting a robust CAGR of 10.7%. This...
Age-Related Macular Degeneration Market to Grow Rapidly by 2032, Predicts DelveInsight | Key Companies - Opthea, Kodiak, Outlook, Apellis, Alkeus, Iveric Bio, Novartis, Luxa Biotechnology, AstraZeneca, Annexon, REGENXBIO
August 21, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Age-Related Macular Degeneration Market to Grow Rapidly by 2032, Predicts DelveInsight | Key Companies - Opthea, Kodiak, Outlook, Apellis, Alkeus,...